This NDC is on FDA's drug shortage list (posted Feb 28, 2025)
Product Information
METHYLPHENIDATE 30 MG/9 HR PATCH is a generic product labeled by Padagis US LLC, priced at $7.8904 per EA under NDC 00574243065. Its NADAC has been published 159 times since Aug 9, 2023.
FDA first approved this application on Apr 6, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
82.5 mg/mg
Manufacturer
Padagis US LLCNDC
00574243065
Classification
Generic
Dosage Form
PATCH
Route
TRANSDERMAL
Effective Date
8/19/2026
Active Ingredients
METHYLPHENIDATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA021514FDA Approved
4/6/2006
TE Code
AB
On Market Since
6/5/2023
Pharmacological Classes
Price Statistics
The NADAC for METHYLPHENIDATE 30 MG/9 HR PATCH has been published 159 times since Aug 9, 2023, and over the history we have for it it has declined 38.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $7.8904 per EA |
|---|---|
| All-time high | $12.8015 (Dec 13, 2023) |
| All-time low | $7.8904 (Aug 19, 2026) |
| 52-week high | $9.7948 |
| 52-week low | $7.8904 |
| Median price | $9.6026 |
| Average price | $10.1418 |
| Largest weekly change | -9.0% (Jul 17, 2024) |
| Weeks tracked | 159 |
| Tracking since | Aug 9, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the methylphenidate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of METHYLPHENIDATE 30 MG/9 HR PATCH?
The current National Average Drug Acquisition Cost (NADAC) for METHYLPHENIDATE 30 MG/9 HR PATCH, manufactured by Padagis US LLC, is $7.8904 per EA (NDC 00574243065), effective Aug 19, 2026.
How has the price of METHYLPHENIDATE 30 MG/9 HR PATCH changed over time?
Over the history we have for it, the NADAC for METHYLPHENIDATE 30 MG/9 HR PATCH has declined 38.4%. It has been tracked across 159 weekly CMS publications since Aug 9, 2023.
What are the highest and lowest recorded NADAC prices for METHYLPHENIDATE 30 MG/9 HR PATCH?
Since Aug 9, 2023, the NADAC for METHYLPHENIDATE 30 MG/9 HR PATCH has ranged from a low of $7.8904 (Aug 19, 2026) to a high of $12.8015 (Dec 13, 2023), with a median of $9.6026 per EA.
Are there cheaper alternatives to METHYLPHENIDATE 30 MG/9 HR PATCH?
No other NADAC-published product currently shares the active ingredient and strength of METHYLPHENIDATE 30 MG/9 HR PATCH in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures METHYLPHENIDATE 30 MG/9 HR PATCH?
METHYLPHENIDATE 30 MG/9 HR PATCH (NDC 00574243065) is labeled by Padagis US LLC, and CMS classifies it as a generic product.
Is METHYLPHENIDATE 30 MG/9 HR PATCH in shortage?
Yes — NDC 00574243065 is currently listed in FDA's drug shortage database (posted Feb 28, 2025).